Content area

Abstract

Breast cancer is a leading cause of cancer-related death in women. Small open reading frame (sORF)-encoded proteins or microproteins constitute a new class of molecules often transcribed from presumed long non-coding RNA transcripts (lncRNAs). The translation of some of these sORFs has been confirmed, but their cellular function and importance remains largely unknown. Here, we report the identification and characterization of a novel microprotein of 10 kDa, which we named Cancer-Associated Small Integral Membrane Open reading frame 1 (CASIMO1). CASIMO1 RNA is overexpressed predominantly in hormone receptor-positive breast tumors. Its knockdown leads to decreased proliferation in multiple breast cancer cell lines. Its loss disturbs the organization of the actin cytoskeleton, leads to inhibition of cell motility, and causes a G0/G1 cell cycle arrest. The proliferation phenotype upon overexpression is observed only with CASIMO1 protein expression, but not with a non-translatable mutant attributing the effects to the sORF-derived protein rather than a lncRNA function. CASIMO1 microprotein interacts with squalene epoxidase (SQLE), a key enzyme in cholesterol synthesis and a known oncogene in breast cancer. Overexpression of CASIMO1 leads to SQLE protein accumulation without affecting its RNA levels and increased lipid droplet clustering, while knockdown of CASIMO1 decreased SQLE protein abundance and ERK phosphorylation downstream of SQLE. Importantly, SQLE knockdown mimicked the CASIMO1 knockdown phenotype and in turn SQLE overexpression fully rescued the effect of CASIMO1 knockdown. These findings establish CASIMO1 as the first functional microprotein that plays a role in carcinogenesis and is implicated in the cell lipid homeostasis.

Details

Title
The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation
Author
Polycarpou-Schwarz, Maria 1 ; Groß, Matthias 1 ; Mestdagh, Pieter 2 ; Schott, Johanna 3 ; Grund, Stefanie E 4 ; Hildenbrand, Catherina 4 ; Rom, Joachim 5 ; Aulmann, Sebastian 6 ; Sinn, Hans-Peter 6 ; Vandesompele, Jo 2   VIAFID ORCID Logo  ; Diederichs, Sven 7 

 Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany 
 Center for Medical Genetics & Cancer Research Institute Ghent (CRIG), Ghent University Belgium, Ghent, Belgium 
 Division of Biochemistry I, Center for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, Heidelberg University, and Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Mannheim, Germany 
 Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany 
 Department of Obstetrics & Gynecology, University Hospital Heidelberg, Heidelberg, Germany 
 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany 
 Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Division of Cancer Research, Department of Thoracic Surgery, Medical Center—University of Freiburg, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany 
Pages
4750-4768
Publication year
2018
Publication date
Aug 2018
Publisher
Nature Publishing Group
ISSN
09509232
e-ISSN
14765594
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2092508841
Copyright
Copyright Nature Publishing Group Aug 2018